{"id":45088,"date":"2019-04-30T18:01:57","date_gmt":"2019-04-30T16:01:57","guid":{"rendered":"https:\/\/blog.cofb.cat\/?p=45088"},"modified":"2019-04-30T18:01:57","modified_gmt":"2019-04-30T16:01:57","slug":"abordatge-cardiodiabesitat-gestio-integral-latencio-centrada-pacient","status":"publish","type":"post","link":"https:\/\/www.cofb.org\/ca\/2019\/04\/30\/abordatge-cardiodiabesitat-gestio-integral-latencio-centrada-pacient\/","title":{"rendered":"Abordatge de la cardiodiabesitat des de la gesti\u00f3 integral i l&#8217;atenci\u00f3 centrada en el pacient"},"content":{"rendered":"<p>El passat 11 d&#8217;abril va tenir lloc al COFB la formaci\u00f3 <strong>&#8220;Cardiodiabesitat: Atenci\u00f3 centrada en el pacient&#8221;<\/strong>, coordinada per Anna Bach-Faig, vocal d&#8217;Alimentaci\u00f3 i Nutrici\u00f3 i Josep Allu\u00e9 Creus, vocal de Plantes Medicinals i Homeopatia.\u00a0 El curs va comptar amb <strong>M. Jos\u00e9 Alonso<\/strong>, farmac\u00e8utica especialista en farm\u00e0cia industrial i gal\u00e8nica; <strong>Mar Blanco<\/strong>, farmac\u00e8utica comunit\u00e0ria i consultora aliment\u00e0ria; <strong>Marta Castells<\/strong>, doctora en farm\u00e0cia experta en nutrici\u00f3; <strong>Montse Iracheta<\/strong>, farmac\u00e8utica comunit\u00e0ria, vocal de l&#8217;executiva catalana de SEFAC i professora associada a la Facultat de Farm\u00e0cia de la UB i <strong>Anna Ram\u00edrez<\/strong>, farmac\u00e8utica del Centre d&#8217;Informaci\u00f3 del Medicament del COFB.<\/p>\n<p>Les sessions, que van combinar teoria i resoluci\u00f3 de diversos casos pr\u00e0ctics, van abordar els aspectes seg\u00fcents:<\/p>\n<ul>\n<li>saber <strong>integrar el tractament del malalt amb cardiodiabesitat<\/strong> (farmacol\u00f2gic, complements alimentosos, fitoterap\u00e8utic, consell alimentari)<\/li>\n<li>poder <strong>actuar davant de les possibles interaccions i assessorar el malalt sobre precaucions a adoptar en l&#8217;\u00fas de medicaments i altres productes<\/strong>, els possibles efectes adversos i les interaccions amb els f\u00e0rmacs prescrits per a les patologies que presenta<\/li>\n<\/ul>\n<figure id=\"attachment_45472\" aria-describedby=\"caption-attachment-45472\" style=\"width: 620px\" class=\"wp-caption aligncenter\"><a href=\"https:\/\/blog.cofb.cat\/wp-content\/uploads\/2019\/04\/cofb.190411-05.jpg\"><img fetchpriority=\"high\" decoding=\"async\" class=\"wp-image-45472 size-large\" title=\"D'esquerra a dreta: Anna Bach-Faig, Marta Castells, Mar Blanco, M. Jos\u00e9 Alonso, Montse Iracheta, Anna Ram\u00edrez i Eva Hortas. \" src=\"https:\/\/blog.cofb.cat\/wp-content\/uploads\/2019\/04\/cofb.190411-05-1024x683.jpg\" alt=\"D'esquerra a dreta: Anna Bach-Faig, Marta Castells, Mar Blanco, M. Jos\u00e9 Alonso, Montse Iracheta, Anna Ram\u00edrez i Eva Hortas. \" width=\"620\" height=\"414\" \/><\/a><figcaption id=\"caption-attachment-45472\" class=\"wp-caption-text\">D&#8217;esquerra a dreta: Anna Bach-Faig, Marta Castells, Mar Blanco, M. Jos\u00e9 Alonso, Montse Iracheta, Anna Ram\u00edrez i Eva Hortas.<\/figcaption><\/figure>\n<h1><span style=\"color: #008080;\"><strong>Atenci\u00f3 centrada en el pacient<\/strong><\/span><\/h1>\n<p>Marta Castells i Montse Iracheta van definir la\u00a0<strong>cardiodiabesitat <\/strong>com el concepte que s&#8217;utilitza per definir i descriure la relaci\u00f3 entre la <em>Diabetis mellitus II<\/em> (DMII), l&#8217;obesitat, la s\u00edndrome metab\u00f2lica i les malalties cardiovasculars (MCV). El terme <strong>cardiodiabesitat<\/strong>, segons van exposar Castells i Iracheta seguint l&#8217;article &#8211;<a href=\"http:\/\/elfarmaceutico.es\/index.php\/nutricion\/item\/5417-abordaje-de-la-cardiodiabesidad-desde-la-farmacia-comunitaria-alimentacion-y-estilo-de-vida#.XML7Brf7SUk\" target=\"_blank\" rel=\"noopener\">&#8220;Abordaje de la cardiodiabesidad desde la farmacia comunitaria: alimentaci\u00f3n y estilo de vida&#8221;<\/a>-, sintetitza la <strong>necessitat de considerar tots els factors de risc<\/strong> i els <strong>resultats de salut<\/strong> en la pr\u00e0ctica cl\u00ednica.<\/p>\n<p>Un altre dels conceptes que es va tractar dins d&#8217;aquest primer bloc de la formaci\u00f3 va ser l&#8217;<strong>atenci\u00f3 centrada en el pacient<\/strong>.\u00a0Segons l&#8217;<em>Institut of Medicine National Academy of Sciences <\/em>es tracta de\u00a0&#8220;l&#8217;atenci\u00f3 que destaca el <strong>respecte<\/strong> i la <strong>resposta individualitzada a les prefer\u00e8ncies, necessitats i valors del pacient<\/strong> assegurant que aquests guien les decisions cl\u00edniques, aix\u00ed com el suport educatiu per part del professional perqu\u00e8 les persones puguin prendre les seves pr\u00f2pies decisions i participar en l&#8217;autocura&#8221;.<\/p>\n<p>En aquest sentit, les ponents van destacar la import\u00e0ncia de l&#8217;<strong>abordatge del pacient<\/strong> establint-hi una relaci\u00f3 de confian\u00e7a; fent escolta activa, sent emp\u00e0tic i sabent identificar el que sap, el que vol saber, el que el preocupa, etc. Des d&#8217;aquesta perspectiva, el m\u00e9s important no \u00e9s el consell que es d\u00f3na sin\u00f3 <strong>com el rep el pacient<\/strong>.\u00a0D&#8217;altra banda, dins d&#8217;aquest bloc, tamb\u00e9 es va fer refer\u00e8ncia al <strong>grau de proactivitat<\/strong> i<strong> implicaci\u00f3<\/strong> <strong>del<\/strong> <strong>pacient<\/strong> (valoraci\u00f3 del grau de coneixement sobre la malaltia, valoraci\u00f3 del risc-benefici; inter\u00e8s pel canvi) i del <strong>farmac\u00e8utic<\/strong>.<\/p>\n<figure id=\"attachment_45470\" aria-describedby=\"caption-attachment-45470\" style=\"width: 620px\" class=\"wp-caption aligncenter\"><a href=\"https:\/\/blog.cofb.cat\/wp-content\/uploads\/2019\/04\/cofb.190411-12.jpg\"><img decoding=\"async\" class=\"wp-image-45470 size-large\" title=\"Un moment de la formaci\u00f3 &quot;Cardiodiabesitat: Atenci\u00f3 centrada en el pacient&quot; celebrada al COFB.\" src=\"https:\/\/blog.cofb.cat\/wp-content\/uploads\/2019\/04\/cofb.190411-12-1024x683.jpg\" alt=\"Un moment de la formaci\u00f3 &quot;Cardiodiabesitat: Atenci\u00f3 centrada en el pacient&quot; celebrada al COFB.\" width=\"620\" height=\"414\" \/><\/a><figcaption id=\"caption-attachment-45470\" class=\"wp-caption-text\">Un moment de la formaci\u00f3 &#8220;Cardiodiabesitat: Atenci\u00f3 centrada en el pacient&#8221; celebrada al COFB.<\/figcaption><\/figure>\n<h2><span style=\"color: #008080;\"><strong>Consell alimentari<\/strong><\/span><\/h2>\n<p>Un cop abordats els <strong>punts clau de la comunicaci\u00f3 farmac\u00e8utic-pacient<\/strong>, van aprofundir en el <strong>consell alimentari<\/strong> en <strong>cardiodiabesitat<\/strong>. Van explicar <strong>qu\u00e8 es necessita saber del pacient<\/strong>\u00a0(com es veu, si reconeix la situaci\u00f3 com un problema de salut, si est\u00e0 disposat a implicar-se en modificar les conductes inadequades per baixar de pes, capacitat per adoptar un estil de vida saludable&#8230;) i <strong>qu\u00e8 necessitem per donar un bon consell farmac\u00e8utic\u00a0<\/strong>(tenir respecte i paci\u00e8ncia, con\u00e8ixer els antecedents familiars i els possibles obstacles socials i econ\u00f2mics, estat d&#8217;\u00e0nim del pacient, nivell d&#8217;activitat f\u00edsica i actitud cap a aquesta&#8230;).<\/p>\n<h1><span style=\"color: #008080;\"><strong>Complements alimentaris i fitoter\u00e0pia en cardiodiabesitat<\/strong><\/span><\/h1>\n<p>Mar Blanco i Maria Jos\u00e9 Alonso van destacar la import\u00e0ncia de preguntar als pacients <strong>si prenen algun medicament<\/strong> quan es dispensa un <strong>producte de fitoter\u00e0pia o complement<\/strong> aix\u00ed com de preguntar <strong>si prenen fitoter\u00e0pia o algun complement<\/strong> quan es dispensa un <strong>medicament<\/strong>. Tot seguit, van aprofundir en les plantes medicinals i els complements en la hipertensi\u00f3, les hiperlipid\u00e8mies i l&#8217;exc\u00e9s de pes. Dins d&#8217;aquest \u00faltim punt, van abordar els <strong>beneficis de l&#8217;exercici f\u00edsic en cardiodiabesitat<\/strong> i la <strong>recomanaci\u00f3 de l&#8217;OMS<\/strong> sobre exercici f\u00edsic. Finalment, tamb\u00e9 es va tractar les plantes medicinals en <em>diabetis mellitus<\/em> tipus II.<\/p>\n<h1><span style=\"color: #008080;\"><strong>Interaccions<\/strong><\/span><\/h1>\n<p>Anna Ram\u00edrez, farmac\u00e8utica del Centre d&#8217;Informaci\u00f3 del Medicament del COFB, va centrar-se en les <strong>interaccions <\/strong>(l&#8217;<strong>efecte inesperat que pot apar\u00e8ixer entre els f\u00e0rmacs i els aliments\/plantes medicinals i\/o complements alimentosos,<\/strong> i<strong>\u00a0<\/strong>que pot ser tant positiu com negatiu, comprometent <strong>l\u2019acci\u00f3 del f\u00e0rmac<\/strong>\u00a0i\/o\u00a0la dels<strong> aliments\/plantes medicinals i\/o complements alimentosos<\/strong>) i va apuntar que &#8220;\u00e9s molt important que els professionals sanitaris disposin de la formaci\u00f3 i informaci\u00f3 espec\u00edfica i de qualitat per detectar-les i evitar-les i ensenyar al pacient com ha de prendre els f\u00e0rmacs en relaci\u00f3 als aliments\/plantes medicinals i\/o complements alimentosos&#8221;.<\/p>\n<figure id=\"attachment_45471\" aria-describedby=\"caption-attachment-45471\" style=\"width: 620px\" class=\"wp-caption aligncenter\"><a href=\"https:\/\/blog.cofb.cat\/wp-content\/uploads\/2019\/04\/cofb.190411-10.jpg\"><img decoding=\"async\" class=\"wp-image-45471 size-large\" title=\"Anna Bach-Faig, una de les coordinadores de la formaci\u00f3.\" src=\"https:\/\/blog.cofb.cat\/wp-content\/uploads\/2019\/04\/cofb.190411-10-1024x683.jpg\" alt=\"Anna Bach-Faig, una de les coordinadores de la formaci\u00f3.\" width=\"620\" height=\"414\" \/><\/a><figcaption id=\"caption-attachment-45471\" class=\"wp-caption-text\">Anna Bach-Faig, una de les coordinadores de la formaci\u00f3.<\/figcaption><\/figure>\n<p>Els\u00a0<strong>f\u00e0rmacs de risc\u00a0<\/strong>que\u00a0 va destacar durant la seva intervenci\u00f3<strong>\u00a0<\/strong>s\u00f3n\u00a0aquells de marge terap\u00e8utic estret, antibi\u00f2tics, estatines, antihipertensius i antiinflamatoris no esteroides (AINES). D&#8217;altra banda, va desglossar els tipus d&#8217;interaccions en funci\u00f3 de quatre categories: f\u00e0rmac-aliments; f\u00e0rmac-plantes medicinals; f\u00e0rmac-complements alimentosos i f\u00e0rmac-f\u00e0rmac. I, finalment,\u00a0 va presentar el dec\u00e0leg d&#8217;interaccions aliment-medicament, plantes medicinals o complements alimentosos elaborat pel COFB, aix\u00ed com diverses <strong>eines per consultar interaccions<\/strong>, com la <a href=\"https:\/\/farmaceutics.cofb.net\/group\/guest\/interaccions-cardiovascular\" target=\"_blank\" rel=\"noopener\"><strong>base de dades d&#8217;acc\u00e9s lliure<\/strong>\u00a0per col\u00b7legiats a la BBS<\/a> sobre interaccions de f\u00e0rmacs cardiovasculars amb <strong>aliments\/plantes medicinals i\/o complements alimentosos de l&#8217;\u00e0mbit cardiovascular.<\/strong><\/p>\n<p style=\"text-align: right;\"><strong>Amb el patrocini de:<\/strong><\/p>\n<p><a href=\"https:\/\/blog.cofb.cat\/wp-content\/uploads\/2019\/04\/Patrocinadors-cardiodiabesitat.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\" wp-image-45476 alignright\" src=\"https:\/\/blog.cofb.cat\/wp-content\/uploads\/2019\/04\/Patrocinadors-cardiodiabesitat.jpg\" alt=\"\" width=\"227\" height=\"57\" \/><\/a><\/p>\n<p>&nbsp;<\/p>\n<p><strong>Altres publicacions d&#8217;inter\u00e8s:<\/strong><\/p>\n<ul>\n<li><a href=\"https:\/\/blog.cofb.cat\/farmaceutics-datencio-primaria-i-de-ladministracio-sanitaria-aprofundeixen-en-el-maneig-del-pacient-diabetic-amb-obesitat\/\" target=\"_blank\" rel=\"noopener\">Farmac\u00e8utics d&#8217;Atenci\u00f3 Prim\u00e0ria i de l&#8217;Administraci\u00f3 Sanit\u00e0ria aprofundeixen en el maneig del pacient diab\u00e8tic amb obesitat (Abril 2019)<\/a><\/li>\n<li><a href=\"https:\/\/blog.cofb.cat\/campanya-atenciodiabetis-present-diabetes-experience-day\/\" target=\"_blank\" rel=\"noopener\">La campanya #Atenci\u00f3Diabetis present al Diabetes Experience Day (Abril 2018)<\/a><\/li>\n<li><a href=\"https:\/\/blog.cofb.cat\/diabetis-malaltia-cardiovascular-mes-enlla-control-glucemia\/\" target=\"_blank\" rel=\"noopener\">Diabetis i malaltia cardiovascular: m\u00e9s enll\u00e0 del control de la gluc\u00e8mia (Febrer 2018)<\/a><\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>El passat 11 d&#8217;abril va tenir lloc al COFB la formaci\u00f3 &#8220;Cardiodiabesitat: Atenci\u00f3 centrada en el pacient&#8221;, coordinada per Anna Bach-Faig, vocal d&#8217;Alimentaci\u00f3 i Nutrici\u00f3 i Josep Allu\u00e9 Creus, vocal de Plantes Medicinals i Homeopatia.\u00a0 El curs va comptar amb M. Jos\u00e9 Alonso, farmac\u00e8utica especialista en farm\u00e0cia industrial i gal\u00e8nica; [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":45470,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[23,57],"tags":[36,561,3471,3472,2356,18,346,271,197,3042,2913,53,69,70,2198,2381,3473,2914,2399],"class_list":["post-45088","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-destacats","category-mon-collegial","tag-alimentacio","tag-aliments","tag-cardiodiabesitat","tag-cardiologia","tag-cardioproteccio","tag-cofb","tag-complements-alimentosos","tag-consell-alimentari","tag-diabetis","tag-estil-de-vida-saludable","tag-factors-de-risc","tag-farmaceutics","tag-farmacia-comunitaria","tag-formacio","tag-malalties-cardiovasculars","tag-obesitat","tag-prediabetics","tag-prediabetis","tag-sindrome-metabolica"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Abordatge de la cardiodiabesitat des de la gesti\u00f3 integral i l&#039;atenci\u00f3 centrada en el pacient - Col\u00b7legi de Farmac\u00e8utics de Barcelona<\/title>\n<meta name=\"description\" content=\"El passat 11 d&#039;abril va tenir lloc al COFB la formaci\u00f3 &quot;Cardiodiabesitat: Atenci\u00f3 centrada en el pacient&quot;, coordinada per Anna Bach-Faig, vocal d&#039;Alimentaci\u00f3 i Nutrici\u00f3 i Josep Allu\u00e9 Creus, vocal de Plantes Medicinals i Homeopatia.\u00a0\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/novaorg.cofb.net\/2019\/04\/30\/abordatge-cardiodiabesitat-gestio-integral-latencio-centrada-pacient\/\" \/>\n<meta property=\"og:locale\" content=\"ca_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Abordatge de la cardiodiabesitat des de la gesti\u00f3 integral i l&#039;atenci\u00f3 centrada en el pacient - Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"og:description\" content=\"El passat 11 d&#039;abril va tenir lloc al COFB la formaci\u00f3 &quot;Cardiodiabesitat: Atenci\u00f3 centrada en el pacient&quot;, coordinada per Anna Bach-Faig, vocal d&#039;Alimentaci\u00f3 i Nutrici\u00f3 i Josep Allu\u00e9 Creus, vocal de Plantes Medicinals i Homeopatia.\u00a0\" \/>\n<meta property=\"og:url\" content=\"https:\/\/novaorg.cofb.net\/2019\/04\/30\/abordatge-cardiodiabesitat-gestio-integral-latencio-centrada-pacient\/\" \/>\n<meta property=\"og:site_name\" content=\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\" \/>\n<meta property=\"article:published_time\" content=\"2019-04-30T16:01:57+00:00\" \/>\n<meta name=\"author\" content=\"wpAdminCofbOrg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:site\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:label1\" content=\"Escrit per\" \/>\n\t<meta name=\"twitter:data1\" content=\"wpAdminCofbOrg\" \/>\n\t<meta name=\"twitter:label2\" content=\"Temps estimat de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minuts\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/novaorg.cofb.net\/2019\/04\/30\/abordatge-cardiodiabesitat-gestio-integral-latencio-centrada-pacient\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2019\/04\/30\/abordatge-cardiodiabesitat-gestio-integral-latencio-centrada-pacient\/\"},\"author\":{\"name\":\"wpAdminCofbOrg\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\"},\"headline\":\"Abordatge de la cardiodiabesitat des de la gesti\u00f3 integral i l&#8217;atenci\u00f3 centrada en el pacient\",\"datePublished\":\"2019-04-30T16:01:57+00:00\",\"dateModified\":\"2019-04-30T16:01:57+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2019\/04\/30\/abordatge-cardiodiabesitat-gestio-integral-latencio-centrada-pacient\/\"},\"wordCount\":1054,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2019\/04\/30\/abordatge-cardiodiabesitat-gestio-integral-latencio-centrada-pacient\/#primaryimage\"},\"thumbnailUrl\":\"\",\"keywords\":[\"alimentaci\u00f3\",\"aliments\",\"cardiodiabesitat\",\"cardiologia\",\"cardioprotecci\u00f3\",\"COFB\",\"complements alimentosos\",\"consell alimentari\",\"diabetis\",\"estil de vida saludable\",\"factors de risc\",\"farmac\u00e8utics\",\"farm\u00e0cia comunit\u00e0ria\",\"Formaci\u00f3\",\"malalties cardiovasculars\",\"obesitat\",\"prediab\u00e8tics\",\"prediabetis\",\"s\u00edndrome metab\u00f2lica\"],\"articleSection\":[\"Destacats\",\"M\u00f3n col\u00b7legial\"],\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/novaorg.cofb.net\/2019\/04\/30\/abordatge-cardiodiabesitat-gestio-integral-latencio-centrada-pacient\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/novaorg.cofb.net\/2019\/04\/30\/abordatge-cardiodiabesitat-gestio-integral-latencio-centrada-pacient\/\",\"url\":\"https:\/\/novaorg.cofb.net\/2019\/04\/30\/abordatge-cardiodiabesitat-gestio-integral-latencio-centrada-pacient\/\",\"name\":\"Abordatge de la cardiodiabesitat des de la gesti\u00f3 integral i l'atenci\u00f3 centrada en el pacient - Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"isPartOf\":{\"@id\":\"https:\/\/www.cofb.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2019\/04\/30\/abordatge-cardiodiabesitat-gestio-integral-latencio-centrada-pacient\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2019\/04\/30\/abordatge-cardiodiabesitat-gestio-integral-latencio-centrada-pacient\/#primaryimage\"},\"thumbnailUrl\":\"\",\"datePublished\":\"2019-04-30T16:01:57+00:00\",\"dateModified\":\"2019-04-30T16:01:57+00:00\",\"description\":\"El passat 11 d'abril va tenir lloc al COFB la formaci\u00f3 \\\"Cardiodiabesitat: Atenci\u00f3 centrada en el pacient\\\", coordinada per Anna Bach-Faig, vocal d'Alimentaci\u00f3 i Nutrici\u00f3 i Josep Allu\u00e9 Creus, vocal de Plantes Medicinals i Homeopatia.\u00a0\",\"breadcrumb\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2019\/04\/30\/abordatge-cardiodiabesitat-gestio-integral-latencio-centrada-pacient\/#breadcrumb\"},\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/novaorg.cofb.net\/2019\/04\/30\/abordatge-cardiodiabesitat-gestio-integral-latencio-centrada-pacient\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/novaorg.cofb.net\/2019\/04\/30\/abordatge-cardiodiabesitat-gestio-integral-latencio-centrada-pacient\/#primaryimage\",\"url\":\"\",\"contentUrl\":\"\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/novaorg.cofb.net\/2019\/04\/30\/abordatge-cardiodiabesitat-gestio-integral-latencio-centrada-pacient\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inici\",\"item\":\"https:\/\/novaorg.cofb.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Abordatge de la cardiodiabesitat des de la gesti\u00f3 integral i l&#8217;atenci\u00f3 centrada en el pacient\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cofb.org\/#website\",\"url\":\"https:\/\/www.cofb.org\/\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cofb.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"ca\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cofb.org\/#organization\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"url\":\"https:\/\/www.cofb.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"width\":500,\"height\":105,\"caption\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\",\"https:\/\/twitter.com\/farmaceuticsbcn\",\"https:\/\/www.instagram.com\/farmaceuticsbcn\/\",\"https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\",\"name\":\"wpAdminCofbOrg\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"caption\":\"wpAdminCofbOrg\"},\"sameAs\":[\"http:\/\/192.168.64.122\/wordpress\"],\"url\":\"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Abordatge de la cardiodiabesitat des de la gesti\u00f3 integral i l'atenci\u00f3 centrada en el pacient - Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"El passat 11 d'abril va tenir lloc al COFB la formaci\u00f3 \"Cardiodiabesitat: Atenci\u00f3 centrada en el pacient\", coordinada per Anna Bach-Faig, vocal d'Alimentaci\u00f3 i Nutrici\u00f3 i Josep Allu\u00e9 Creus, vocal de Plantes Medicinals i Homeopatia.\u00a0","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/novaorg.cofb.net\/2019\/04\/30\/abordatge-cardiodiabesitat-gestio-integral-latencio-centrada-pacient\/","og_locale":"ca_ES","og_type":"article","og_title":"Abordatge de la cardiodiabesitat des de la gesti\u00f3 integral i l'atenci\u00f3 centrada en el pacient - Col\u00b7legi de Farmac\u00e8utics de Barcelona","og_description":"El passat 11 d'abril va tenir lloc al COFB la formaci\u00f3 \"Cardiodiabesitat: Atenci\u00f3 centrada en el pacient\", coordinada per Anna Bach-Faig, vocal d'Alimentaci\u00f3 i Nutrici\u00f3 i Josep Allu\u00e9 Creus, vocal de Plantes Medicinals i Homeopatia.\u00a0","og_url":"https:\/\/novaorg.cofb.net\/2019\/04\/30\/abordatge-cardiodiabesitat-gestio-integral-latencio-centrada-pacient\/","og_site_name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","article_publisher":"https:\/\/www.facebook.com\/farmaceuticsbcn\/","article_published_time":"2019-04-30T16:01:57+00:00","author":"wpAdminCofbOrg","twitter_card":"summary_large_image","twitter_creator":"@farmaceuticsbcn","twitter_site":"@farmaceuticsbcn","twitter_misc":{"Escrit per":"wpAdminCofbOrg","Temps estimat de lectura":"5 minuts"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/novaorg.cofb.net\/2019\/04\/30\/abordatge-cardiodiabesitat-gestio-integral-latencio-centrada-pacient\/#article","isPartOf":{"@id":"https:\/\/novaorg.cofb.net\/2019\/04\/30\/abordatge-cardiodiabesitat-gestio-integral-latencio-centrada-pacient\/"},"author":{"name":"wpAdminCofbOrg","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb"},"headline":"Abordatge de la cardiodiabesitat des de la gesti\u00f3 integral i l&#8217;atenci\u00f3 centrada en el pacient","datePublished":"2019-04-30T16:01:57+00:00","dateModified":"2019-04-30T16:01:57+00:00","mainEntityOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2019\/04\/30\/abordatge-cardiodiabesitat-gestio-integral-latencio-centrada-pacient\/"},"wordCount":1054,"commentCount":0,"publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2019\/04\/30\/abordatge-cardiodiabesitat-gestio-integral-latencio-centrada-pacient\/#primaryimage"},"thumbnailUrl":"","keywords":["alimentaci\u00f3","aliments","cardiodiabesitat","cardiologia","cardioprotecci\u00f3","COFB","complements alimentosos","consell alimentari","diabetis","estil de vida saludable","factors de risc","farmac\u00e8utics","farm\u00e0cia comunit\u00e0ria","Formaci\u00f3","malalties cardiovasculars","obesitat","prediab\u00e8tics","prediabetis","s\u00edndrome metab\u00f2lica"],"articleSection":["Destacats","M\u00f3n col\u00b7legial"],"inLanguage":"ca","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/novaorg.cofb.net\/2019\/04\/30\/abordatge-cardiodiabesitat-gestio-integral-latencio-centrada-pacient\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/novaorg.cofb.net\/2019\/04\/30\/abordatge-cardiodiabesitat-gestio-integral-latencio-centrada-pacient\/","url":"https:\/\/novaorg.cofb.net\/2019\/04\/30\/abordatge-cardiodiabesitat-gestio-integral-latencio-centrada-pacient\/","name":"Abordatge de la cardiodiabesitat des de la gesti\u00f3 integral i l'atenci\u00f3 centrada en el pacient - Col\u00b7legi de Farmac\u00e8utics de Barcelona","isPartOf":{"@id":"https:\/\/www.cofb.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2019\/04\/30\/abordatge-cardiodiabesitat-gestio-integral-latencio-centrada-pacient\/#primaryimage"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2019\/04\/30\/abordatge-cardiodiabesitat-gestio-integral-latencio-centrada-pacient\/#primaryimage"},"thumbnailUrl":"","datePublished":"2019-04-30T16:01:57+00:00","dateModified":"2019-04-30T16:01:57+00:00","description":"El passat 11 d'abril va tenir lloc al COFB la formaci\u00f3 \"Cardiodiabesitat: Atenci\u00f3 centrada en el pacient\", coordinada per Anna Bach-Faig, vocal d'Alimentaci\u00f3 i Nutrici\u00f3 i Josep Allu\u00e9 Creus, vocal de Plantes Medicinals i Homeopatia.\u00a0","breadcrumb":{"@id":"https:\/\/novaorg.cofb.net\/2019\/04\/30\/abordatge-cardiodiabesitat-gestio-integral-latencio-centrada-pacient\/#breadcrumb"},"inLanguage":"ca","potentialAction":[{"@type":"ReadAction","target":["https:\/\/novaorg.cofb.net\/2019\/04\/30\/abordatge-cardiodiabesitat-gestio-integral-latencio-centrada-pacient\/"]}]},{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/novaorg.cofb.net\/2019\/04\/30\/abordatge-cardiodiabesitat-gestio-integral-latencio-centrada-pacient\/#primaryimage","url":"","contentUrl":""},{"@type":"BreadcrumbList","@id":"https:\/\/novaorg.cofb.net\/2019\/04\/30\/abordatge-cardiodiabesitat-gestio-integral-latencio-centrada-pacient\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inici","item":"https:\/\/novaorg.cofb.net\/"},{"@type":"ListItem","position":2,"name":"Abordatge de la cardiodiabesitat des de la gesti\u00f3 integral i l&#8217;atenci\u00f3 centrada en el pacient"}]},{"@type":"WebSite","@id":"https:\/\/www.cofb.org\/#website","url":"https:\/\/www.cofb.org\/","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"","publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cofb.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"ca"},{"@type":"Organization","@id":"https:\/\/www.cofb.org\/#organization","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","url":"https:\/\/www.cofb.org\/","logo":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","width":500,"height":105,"caption":"Col\u00b7legi de Farmac\u00e8utics de Barcelona"},"image":{"@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/farmaceuticsbcn\/","https:\/\/twitter.com\/farmaceuticsbcn","https:\/\/www.instagram.com\/farmaceuticsbcn\/","https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/"]},{"@type":"Person","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb","name":"wpAdminCofbOrg","image":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","caption":"wpAdminCofbOrg"},"sameAs":["http:\/\/192.168.64.122\/wordpress"],"url":"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/"}]}},"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false,"trp-custom-language-flag":false},"uagb_author_info":{"display_name":"wpAdminCofbOrg","author_link":"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/"},"uagb_comment_info":0,"uagb_excerpt":"El passat 11 d&#8217;abril va tenir lloc al COFB la formaci\u00f3 &#8220;Cardiodiabesitat: Atenci\u00f3 centrada en el pacient&#8221;, coordinada per Anna Bach-Faig, vocal d&#8217;Alimentaci\u00f3 i Nutrici\u00f3 i Josep Allu\u00e9 Creus, vocal de Plantes Medicinals i Homeopatia.\u00a0 El curs va comptar amb M. Jos\u00e9 Alonso, farmac\u00e8utica especialista en farm\u00e0cia industrial i gal\u00e8nica; [&hellip;]","_links":{"self":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/45088","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/comments?post=45088"}],"version-history":[{"count":0,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/45088\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/"}],"wp:attachment":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/media?parent=45088"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/categories?post=45088"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/tags?post=45088"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}